TURKISH PHARMACEUTICALS AND MEDICAL DEVICES COUNCIL, VICE PRESIDENT OF PHARMACY AND PHARMACY, EXPERT. PHARMACY WE VISITED MESİL AKSOY IN HIS OFFICE

Turkey Pharmaceuticalsç and Medical Device Agency Pharmaceuticalsç and Vice President of Pharmacy, Expert. Pharmac. We visited Mesil Aksoy in his office.

Within the scope of the latest regulations affecting SMA patients' access to treatment, the new criteria are those who need permanent invasive mechanical respiratory support for more than 16 hours and are fed with a percutaneous gastrostomy tube. The effects it may have on patients are discussed. It has been stated that the newly introduced criteria include restrictive conditions that were not included in previous practices, and that this situation may create restrictions for patients in accessing treatment. Our request that it should be reviewed was shared with Mr. Aksoy.

Dear Specialist for your kind hosting. Pharmac. We would like to thank Mesil Aksoy and his valuable team.